Parkinson’s Disease, a neurodegenerative disease, may show early signs of tremor at rest and slowness of movement, and is followed by problems with unstable gait, falling, “freezing”, rigidity, drooling, mood disorders, dementia, handwriting difficulties, fixed facial expressions, infrequent blinking, very quiet speech, sleep disorders, inability to smell, problems with bladder and intestinal function, and/or sexual dysfunction. Some of these may be controlled with dopamine medications, while others require other forms of therapy.
Treatment by Stem Cell Genetic Med consists of the following:
- Neurogenesis in which patients will receive injectable and oral agents to stimulate the patients own neuron cells near the substantia nigra.
- Autologous stem cells extracted from the patient’s peripheral blood or bone marrow.
- The neuron brain stem cells that secrete dopamine and brain derived neurotrophic factor, nerve growth factor, glial derived neurotrophic factor, neurotrophins3/4 are given intrathecally into the lower spinal canal thus allowing passage through the blood brain barrier. The procedure is safe, painless and non-surgical.
- Post operative consists of continued emphasis on stimulating the patient’s own neuron stem cells and nerve growth factors, as well as the new exogenous stem cells that were administered intravenously or into the spinal canal and central nervous system. This will be done with both oral and injectable agents.
- Anti-oxidants and anti-inflammatories agents to reduce excess levels of the neurotransmitter glutamate and reduce programmed nerve cell death (apoptosis).
- Patients will be followed at the Stem Cell Genetic Med Clinic and/or by regular appointments via telemedicine webcam